DarioHealth to Host Webinar for Investors on Navigating Emerging Digital Health Trends for Strategic Growth in 2022
NEW YORK, January 18, 2022 /PRNewswire/ — DarioHealth Corp. (Nasdaq: DRIO), a global market leader in digital therapeutics (DTx), today announced that it will host an investor webinar on navigating emerging digital health trends in 2022 on Wednesday January 19and at 8 a.m. ET.
Join DarioHealth management and two renowned industry experts from Rock Health and Mercer to better understand how the tailwinds of the evolving digital health landscape are fueling the company’s strategic approach for 2022.
Sari Kaganoff, Managing Director of Consulting at Rock Health, brings deep experience advising businesses on digital health strategy and innovation, sharing emerging trends shaping the digital health landscape in 2022 and beyond.
David Kaplan, former Head of Mercer’s Healthcare Practice, is a highly regarded healthcare innovator specializing in the commercialization of digital healthcare solutions, offering key insights into industry trends shaping opportunities in the markets for employers, providers and payers.
Finally, Erez Raphael, CEO of DarioHealth, and Rick Anderson, President and CEO of DarioHealth for North America, will provide a deep dive into the company’s digital therapy platform, including a demonstration of the seamless user experience at the heart of user adoption on its polychronic platform. They will summarize the company’s key achievements in 2021 and outline the strategic roadmap propelling the company to category leadership and business activity in 2022.
DarioHealth is transforming healthcare with its cloud-based digital therapy platform that delivers personalized care when and where patients need it for a range of health conditions. Our single platform connects services, devices and people at scale, ensuring clinical and financial outcomes that positively impact tens of millions of lives and save billions of dollars.
To register for the event, please click here.
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading global digital therapy company that is revolutionizing the way people with chronic conditions manage their health. DarioHealth offers one of the most comprehensive digital therapeutic solutions on the market – covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within an integrated technology platform.
Dario’s next-generation AI-powered digital therapy platform supports more than just an individual’s illness. Dario delivers adaptive, personalized experiences that drive behavior change through evidence-based interventions, intuitive and clinically proven digital tools, high-quality software, and coaching to help individuals improve their health and maintain significant results.
Dario’s unique, user-centric approach to product design and engagement creates an unparalleled experience that is highly valued by users and delivers lasting results.
The company’s cross-functional team operates at the intersection of life sciences, behavioral sciences and software technology and uses a performance-based approach to improve the health of its users.
On the path to better health, Dario makes the right thing to do the easiest thing to do. To learn more about DarioHealth and its digital health solutions, or for more information, visit http://dariohealth.com.
Caution Regarding Forward-Looking Statements
This press release and statements from representatives and partners of DarioHealth Corp. relating thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. For example, the Company uses forward-looking statements in this press release when discussing the expected timeline of new customers delivering the Dario platform and solution to its users, that the agreements will contribute to 2022 revenue, and the belief that Employers find value in its integrated multi-condition suite versus individual point solutions and looks forward to expanding its customers through the full suite this year. Without limiting the generality of the foregoing, words such as “plan”, “project”, “potential”, “seek”, “may”, “will”, “expect”, “believe”, “anticipate “, “intend,” “could,” “estimate,” or “go” are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company’s actual results and could cause such results differ materially from any forward-looking statements that may be made in this press release. Factors that could affect the Company’s results include, but are not limited to, regulatory approvals, product demand, market acceptance, market, the impact of competitive products and prices, product development, marketing or technological difficulties, the success or failure of trade negotiations and exchanges, legal, social and economic risks. ues, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company’s actual results and the forward-looking statements include, but are not limited to, the risks discussed in the Company’s filings with the U.S. Securities and Exchange Commission. United. Readers are cautioned that actual results (including, without limitation, the timing and results of the Company’s commercial and regulatory plans for Dario™ as described herein) may differ materially from those set forth in the statements. prospective. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
Corporate Contact DarioHealth
Suzanne Bedell
Marketing Vice President
[email protected]
+1-347-767-4220
Media Contact:
Josephine Galatioto
[email protected]
+1-212-845-4262
Logo – http://mma.prnewswire.com/media/544126/DarioHealth_Logo.jpg
SOURCEDarioHealth Corp.
